HealthLynked Corp. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HealthLynked Corp. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $3.25K, a 98.73% decline year-over-year.
- HealthLynked Corp. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $38.82K.
- HealthLynked Corp. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $255.92K.
- HealthLynked Corp. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $8.28K, a 95.34% decline year-over-year.
- HealthLynked Corp. stock issued during period, value, new issues for fiscal 2021 was $4.77M, a 376.51% increase from fiscal 2020.
- HealthLynked Corp. stock issued during period, value, new issues for fiscal 2020 was $1.00M, a 33.46% decline from fiscal 2019.
- HealthLynked Corp. stock issued during period, value, new issues for fiscal 2019 was $1.50M, a 38.63% decline from fiscal 2018.
- HealthLynked Corp. stock issued during period, value, new issues for fiscal 2018 was $2.45M, a 222.83% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $3.25K S-1/A · filed 2026-05-29 | |
| 2025-03-31 | $3.25K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $294.74K S-1/A · filed 2026-05-29 | |
| 2024-06-30 | $38.82K 10-Q · filed 2025-11-19 | |
| 2024-03-31 | $255.92K 10-Q · filed 2025-11-19 | |
| 2022-06-30 | $8.28K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-03-31 | $4.77M 10-K · filed 2022-03-31 |
| 2021-09-30 | $1.61M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $177.68K 10-Q · filed 2021-11-15 | |
| 2021-03-31 | $2.98M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $1.00M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $317.16K 10-Q · filed 2021-11-15 | $1.34M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $253.78K 10-Q · filed 2021-11-15 | $1.27M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-03-31 | $348.60K 10-Q · filed 2021-11-15 | $1.16M derived: sum of 4 quarters · filed 2021-11-15 |
| 2019-12-31 | $418.37K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.50M 10-K · filed 2021-03-31 |
| 2019-09-30 | $246.34K 10-Q · filed 2020-11-16 | $1.20M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $145.46K 10-Q · filed 2020-11-16 | $2.79M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-03-31 | $694.16K 10-Q · filed 2020-11-16 | $3.01M derived: sum of 4 quarters · filed 2020-11-16 |
| 2018-12-31 | $112.76K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $2.45M 10-K · filed 2020-03-30 |
| 2018-09-30 | $1.84M 10-Q · filed 2019-11-14 | $2.55M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $365.87K 10-Q · filed 2019-08-14 | $738.75K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $133.61K 10-Q · filed 2019-08-14 | $682.88K derived: sum of 4 quarters · filed 2019-08-14 |
| 2017-12-31 | $210.91K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $759.26K 10-K · filed 2019-04-01 |
| 2017-09-30 | $28.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | |
| 2017-06-30 | $310.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | |
| 2017-03-31 | $210.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $374.00K 10-K · filed 2018-04-02 |